Psoriatic Arthritis Clinical Trials

A listing of Psoriatic Arthritis medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 40 clinical trials
Study on the Safety for the Newborn of the Use of Biologics During Pregnancy by Mothers Affected by Autoimmune Diseases

The goal of the study is to evaluate the effects on the offspring and therefore the safety of using biologic agents during pregnancy and their eventual consequences on children. The effects considered are divided into peri-partum and more long-term effects. Demonstration of safety in children born from mothers who received …

  • 0 views
  • 23 Jan, 2021
  • 1 location
Investigating the Utilisation and Effectiveness of Originator and Biosimilar Anti-TNF Agents

An observational study investigating the utilisation and effectiveness of originator and biosimilar anti-TNF agents in patients with rheumatoid arthritis, psoriatic arthritis, or ankylosing

spondylitis
biosimilar
arthritis
tumor necrosis factor
ankylosing spondylitis
  • 821 views
  • 22 Jan, 2021
  • 22 locations
Psoriasis Longitudinal Assessment and Registry

receiving other therapies, such as non-biologic and other biologic agents. The registry also evaluates patient and disease characteristics, including patient-reported assessment of psoriatic arthritis (PsA

guselkumab
arthritis
brodalumab
secukinumab
psoriasis
  • 4031 views
  • 18 Jun, 2021
  • 486 locations
PANLAR's Latin American Registry of Rheumatic Patients Treated With Jak Inhibitors

This prospective, non-interventional, research registry is designed to study the comparative safety and comparative effectiveness of approved Jak Inhibitors treatment for RA-PsA-SpA in a cohort of patients and theirs controls cared for by rheumatologists across Latin Amrica (LA).

  • 0 views
  • 05 Apr, 2021
  • 2 locations
Evaluation of Patient Satisfaction and Therapeutic Impact Regarding Joint Consultation Rheumatologist/Dermatologist

Current increase in the number of multidisciplinary consultations, but little documentation on their impact on patient management. More specifically, in the context of psoriatic arthritis, we

  • 0 views
  • 21 Mar, 2021
  • 1 location
Korean College of Rheumatology Biologics Registry

We plan to establish a nationwide Biologics Registry (in the form of an inception cohort) to study the safety profiles in rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis

arthritis
biologic disease-modifying antirheumatic drug
rheumatoid arthritis
spondylitis
DMARD
  • 35 views
  • 25 Jan, 2021
  • 1 location
One-year Persistence to Treatment of Participants Receiving Flixabi or Imraldi: a French Cohort Study

: Rheumatoid Arthritis (RA), Ankylosing Spondylitis (AS), Psoriatic Arthritis (PsA), Crohn's Disease (CD) [adults and children] and Ulcerative Colitis (UC) [adults for both treatments and children only for

arthritis
ulcerative colitis
infliximab
rheumatoid arthritis
spondylitis
  • 38 views
  • 24 Jan, 2021
  • 8 locations
PsoBest - The German Psoriasis Registry

Treatment of moderate to severe Psoriasis (Pso) and Psoriasis-Arthritis (PsA) is largely confined to systemic therapy in Germany. Systemic therapy includes conventional systemic therapy (e.g. fumaric acids, methotrexate, ciclosporin A) and biological treatment (e.g. adalimumab, etanercept). While short- and middle-term efficacy of most systemic treatments has been shown in clinical …

arthritis
etanercept
psoriasis
biological treatment
cyclosporine
  • 59 views
  • 22 Jan, 2021
  • 1 location
Post-Marketing Surveillance Study of OTEZLA

To evaluate the safety and efficacy of OTEZLA in actual clinical settings of use in patients with Psoriasis vulgaris that is with an inadequate response to topical therapies and Psoriasis

psoriasis vulgaris
topical agents
  • 46 views
  • 24 Jan, 2021
  • 1 location
Korean Post-marketing Surveillance for Xeljanz

The objective of this study is to identify any problems and questions with respect to the safety and efficacy of Xeljanz during the post-marketing period as required by the regulation of MFDS.

antirheumatics
psoriatic arthritis
anti-rheumatic drugs
DMARD
  • 120 views
  • 28 Jan, 2021
  • 46 locations